$15 Billion in Contracts Estimated at AFED 2018

A part of AFED 2018 exhibition. (SPA)
A part of AFED 2018 exhibition. (SPA)
TT

$15 Billion in Contracts Estimated at AFED 2018

A part of AFED 2018 exhibition. (SPA)
A part of AFED 2018 exhibition. (SPA)

The Armed Forces Exhibition for Diversity of Requirements and Capabilities (AFED 2018) registered around 57,600 manufacturing orders in Saudi Arabia, while the contracts amounted to more than $15 billion.

The exhibition, organized by the Saudi Ministry of Defense at its fourth session in Riyadh, was a platform for boosting local manufacturing. More than 120,000 visitors attended the event, which concluded on Sunday.

AFED 2018 focused on localization of local content by presenting 80,000 manufacturing opportunities to investors, with the participation of civil and military officials in Saudi Arabia and abroad.

About 68 international and 130 local companies participated in the exhibition, including research institutions at the King Abdulaziz City for Science and Technology and Prince Sultan Advanced Research Institute.

The exhibition witnessed the signing of an agreement on the localization of military technology.

CEO of Middle East Propulsion Company Ltd, Abdullah al-Omari said it was signed with General Electric and the Saudi Air Force for the assembly and maintenance of new F15-S and F15-SA aircraft, Apache engines, and the Black Hawk T700 for more than $330 million.

He revealed that this agreement will generate revenues worth $693 million in the upcoming five years.

In addition, KACST offered a package of military and security projects that have been relocated to Saudi Arabia, such as a laser-guided short-range rocket powered by a solid fuel engine, as well as a short-range ballistic missile with a solid fuel engine.

The King Abdulaziz City also presented Custodian of the Two Holy Mosques King Salman bin Abdulaziz’s initiative to desalinate water using solar energy in al-Khafji province to produce 60,000 cubic meters of desalinated water per day.

The Ministry of National Guard showcased at AFED four modern vehicles that were assembled locally at Ministry facilities. This led to the creation of 294 manufacturing opportunities and contributed to the support of local manufacturing and achieving Vision 2030.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.